395 related articles for article (PubMed ID: 32655268)
1. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
[TBL] [Abstract][Full Text] [Related]
4. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
Ogutmen Koc D; Bektas S
Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
[TBL] [Abstract][Full Text] [Related]
5. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
[TBL] [Abstract][Full Text] [Related]
6. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
7. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
[TBL] [Abstract][Full Text] [Related]
8. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
Na YS; Kim SG; Cho SJ
Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
[TBL] [Abstract][Full Text] [Related]
11. OLGA- and OLGIM-Based Staging in the Patients with Gastritis and Endoscopy Indications.
Mansour-Ghanaei F; Joukar F; Yeganeh S; Sadeghi M; Daryakar A; Sepehrimanesh M
Turk J Gastroenterol; 2022 Feb; 33(2):95-102. PubMed ID: 35238779
[TBL] [Abstract][Full Text] [Related]
12. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.
Capelle LG; de Vries AC; Haringsma J; Ter Borg F; de Vries RA; Bruno MJ; van Dekken H; Meijer J; van Grieken NC; Kuipers EJ
Gastrointest Endosc; 2010 Jun; 71(7):1150-8. PubMed ID: 20381801
[TBL] [Abstract][Full Text] [Related]
13.
Wu M; Feng S; Qian M; Wang S; Zhang K
Risk Manag Healthc Policy; 2022; 15():2243-2255. PubMed ID: 36475275
[TBL] [Abstract][Full Text] [Related]
14. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems.
Cho SJ; Choi IJ; Kook MC; Nam BH; Kim CG; Lee JY; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2013 Nov; 38(10):1292-302. PubMed ID: 24134499
[TBL] [Abstract][Full Text] [Related]
15. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
[TBL] [Abstract][Full Text] [Related]
16. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia.
Marcos-Pinto R; Carneiro F; Dinis-Ribeiro M; Wen X; Lopes C; Figueiredo C; Machado JC; Ferreira RM; Reis CA; Ferreira J; Pedroto I; Areias J
Aliment Pharmacol Ther; 2012 Jun; 35(12):1451-9. PubMed ID: 22548492
[TBL] [Abstract][Full Text] [Related]
17. Long-term gastric cancer risk in male smokers with atrophic corpus gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
Scand J Gastroenterol; 2019 Feb; 54(2):145-151. PubMed ID: 30700174
[TBL] [Abstract][Full Text] [Related]
18. Effect of biopsy site on detection of gastric cancer high-risk groups by OLGA and OLGIM stages.
Kim YI; Kook MC; Cho SJ; Lee JY; Kim CG; Joo J; Choi IJ
Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28940945
[TBL] [Abstract][Full Text] [Related]
19. A single vial is enough in the absence of endoscopic suspected intestinal metaplasia - less is more!
Castro R; Esposito G; Libânio D; Afonso L; Annibale B; Dinis-Ribeiro M; Pimentel-Nunes P
Scand J Gastroenterol; 2019 May; 54(5):673-677. PubMed ID: 31084230
[No Abstract] [Full Text] [Related]
20. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
